Draft Medical Policies


Participating providers are invited to submit for consideration scientific, evidence-based information, professional consensus opinions, and other information supported by medical literature relevant to our draft policies.

We accept comments for 45 days from the posting date listed on the draft policy. Make sure your voice is heard by providing feedback directly to us.

How to Submit Comments on Draft Medical Policies

Complete our medical policy feedback form online or send comments and supporting documentation to us by mail or fax:

Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001

Fax: 205-220-0878

Current Draft Policies

Policy # Policy Title Print View
MP-410 Fetal Surgery for Prenatally Diagnosed Malformations
MP-461 Holter Monitoring (Ambulatory Electrocardiography)
MP-468 Molecular Analysis for Targeted Therapy of Non-Small-Cell Lung Cancer (NSCLC)
MP-483 Transcatheter Aortic-Valve Implantation for Aortic Stenosis
MP-537 Peroral Endoscopic Myotomy (POEM) for Treatment of Esophageal Achalasia and Refractory Gastroparesis
MP-719 Surgical Treatments for Lymphedema and Lipedema
MP-724 Hydrogel Spacer use During Radiotherapy for Prostate Cancer
MP-732 Testing Serum Vitamin D Levels